As Cancer Symposium 2024 draws to a close, we take a moment to reflect on the remarkable advancements, discussions, and shared knowledge that have come to define this annual event. Now in its 3rd year, the Cancer Symposium has established itself as a vital platform for healthcare professionals to exchange ideas, explore groundbreaking research, and advance their expertise in cancer care.
This year’s symposium was led by Symposium Chairman Dr. Sandip Kumar and Co-Chairman Dr. Teo Yin Keong, both of whom underscored the event's focus on enhancing multidisciplinary collaboration and empowering professionals with the latest insights into oncology. Under their leadership, the symposium provided a comprehensive view of oncology's evolving landscape, including the importance of integrating technology, research, and patient-centered strategies into everyday practice.
A centerpiece of Cancer Symposium 2024 was the exploration of pioneering approaches to early detection and diagnosis. Sessions included in-depth discussions on the latest in diagnostic tools and AI-enhanced imaging, with experts demonstrating how these technologies can identify cancer in its earliest and most treatable stages. Immunotherapy was also a focal point, with discussions on how innovative therapies are reshaping treatment protocols and offering renewed hope to patients with previously limited options.
Participants were also inspired by sessions emphasizing holistic patient care. Oncology is not just about treatment—it is also about supporting patients through every stage of their journey, from diagnosis to recovery. The symposium provided a space for healthcare providers to share best practices in delivering comprehensive, compassionate care, ensuring that patients' physical, emotional, and mental well-being are prioritized.
Reflecting Gleneagles Hospital Johor’s commitment to excellence, Cancer Symposium 2024 was attended by a wide range of medical professionals, from oncologists to surgeons, all eager to deepen their understanding and improve their practice. As a leading institution in Southern Malaysia, Gleneagles Hospital Johor is dedicated to driving forward the standard of oncology care in the region.
With the Cancer Symposium as a cornerstone event, the hospital remains steadfast in its mission to uplift the quality of cancer treatment and establish a foundation for continual innovation in patient care. We are inspired to continue our journey toward a future where every patient benefits from the best care available, supported by cutting-edge research and collaborative expertise.
EN
Find A Doctor
Request an Appointment
International Patient
+607 560 1000
+607 560 1111
